✦ LIBER ✦

Safety and Efficacy of Neo-adjuvant Sequential Dose-Dense Chemotherapy Doublets Combined with Trastuzumab in Patients with HER-2-Positive Early Stage Breast Cancer

✍ Scribed by Alfonso Sánchez-Muñoz; Ana Maria García-Tapiador; Rosario Dueñas-García; Ana Jaén-Morago; Ana Laura Ortega-Granados; Esther Martínez-Ortega; Margarita Fernández Morales; Mónica Fernández-Navarro; Capilla De La Torre Cabrera; Basilio Dueñas; Crisostomo Ureña; Julia Martínez; Francisco Morales; César Ramírez-Tortosa; Pedro Sánchez-Rovira

Book ID: 109079723
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 43 KB
Volume: 14
Category: Article
ISSN: 1075-122X
DOI: 10.1111/j.1524-4741.2008.00634.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of trastuzumab plus

Efficacy and safety of trastuzumab plus capecitabine in heavily pretreated patients with HER2-positive metastatic breast cancer

✍ Tomo Osako; Yoshinori Ito; Shunji Takahashi; Nahomi Tokudome; Takuji Iwase; Kiyo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 293 KB

Evaluation of the prognostic value of HE

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

✍ Ioannis Kostopoulos; Petroula Arapantoni-Dadioti; Helen Gogas; Savvas Papadopoul 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 406 KB

A pilot study of adjuvant nanoparticle a

A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer

✍ Denise Yardley; Howard Burris; Nancy Peacock; Eric Raefsky; Marianne Melnik; Rog 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 171 KB